Impax Laboratories to Present at the Credit Suisse 2012 Healthcare Conference

Mark Donohue, 215-558-4526Sr. Director, Investor Relations and Corporate Communications

today announced that the Company will present at the Credit Suisse 2012 Healthcare Conference on Wednesday, November 14, at 1:00 p.m. Mountain Standard Time. The conference will be held at the Arizona Biltmore Hotel located in Phoenix, AZ.

Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company’s web site at . This presentation will be archived on the Company’s web site for 30 days.

Impax Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax has developed marketing partnerships to fully leverage its technology platform. Impax Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward, Philadelphia and Taiwan facilities. For more information, please visit the Company's Web site at: .

Suggested Articles

Orum Therapeutics raised $30 million to expand the applications for for its cell-penetrating antibody technology.

Genentech followed a $1 billion pact with Sosei Heptares with discovery deals around cancer and neurological diseases with Skyhawk and Convelo.

The partners will use wearable devices to assess how heart failure patients function and feel after being discharged from hospitals.